Adaptive Biotechnologies Corporation Common Stock
ADPT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of ADPT by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Ro Khanna House / D | Purchase $1,001 - $15,000 | N/A |
ADPT Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
---
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
ADPT Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
ADPT Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in ADPT holdings by institutional investors
Quarterly net insider trading by ADPT's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$30,000 Jan 19, 2024 Issue: Health Issues
-
$30,000 Oct 16, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$60,000 Jul 18, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$70,000 Jan 18, 2023 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$80,000 Oct 17, 2022 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
-
$70,000 Jul 12, 2022 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
-
$240,000 Mar 23, 2022 Issue: Medicare/Medicaid Health Issues
-
$190,000 Jan 21, 2022 Issue: None
-
$140,000 Oct 20, 2021 Issue: None
-
$120,000 Jul 15, 2021 Issue: None
-
$130,000 Apr 20, 2021 Issue: HEALTH ISSUES
-
$190,000 Jan 21, 2021 Issue: HEALTH ISSUES
-
$80,000 Oct 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
-
$30,000 Apr 20, 2015 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
Former government officials who have lobbied for ADPT
10 former government officials from 4 congressional offices at 2 lobbying firms have lobbied for ADPT, most recently Apr 13, 2023.
-
Katie Brown House New Senior Legislative Assistant, Rep. GT Thompson (2015-17); Health Policy Advisor/Legislative Aide, Rep. Mike Fitzpatrick (2013-15); Scheduler, Rep. Mike Fitzpatrick (2012-13); Staff Assistant/Constituent Advocate, Rep. Mike Fitzpatrick (2011-12)
-
Natalie Tietjen House New Intern, Rep. Watson Coleman (2018)
-
Pamela Bradley Other covered legislative branch official
-
Peter Duyshart House New Program Support Student Trainee, Secretarial Internship Program, U.S. DOT (2020); Intern, Rep. Karen Bass (2015-2016); Extern, U.S. Attorneys Office, Central District of California (2015) -
Bobby Mcmillin Senate New General Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Chambliss (2007) -
Kristine Blackwood Congress New Deputy Dir. for Cong. Oversight, HHS (2010-15); Chief Counsel, Senate Aging (09-10); Investigative Counsel, House E&C (07-08); Attorney-Advisor, DOJ Leg Affairs (05-07); Healthcare Fraud Coordinator, DOJ (03-05); AUSA, Central District CA (94-03)
-
Pari Mody Executive New Intern, HHS Office of General Counsel Public Health (2013)
-
Eugenia Pierson House New House Energy and Commerce Committee (2001-05)
ADPT Estimated quarterly lobbying spending
ADPT Revenue by Segment or Geography
By Segment
By Geography
ADPT Income Statement
ADPT Balance Sheet
ADPT Cash Flow
U.S. Patents
New ADPT patent grants
-
Patent Title: Determining wt-1-specific t cells and wt-1 specific t cell receptors (tcrs) Jun. 02, 2026
-
Patent Title: Methods of monitoring conditions by sequence analysis Apr. 21, 2026
-
Patent Title: Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing Sep. 30, 2025
-
Patent Title: Determining antigen-specific t-cells Jul. 08, 2025
-
Patent Title: T cell receptor sequences diagnostic for covid-19 and related compositions Apr. 01, 2025
-
Patent Title: Lyme disease-associated t cell receptor-related methods Apr. 01, 2025
-
Patent Title: Monitoring health and disease status using clonotype profiles Jan. 28, 2025
-
Patent Title: Synthetic strands for nucleic acid sequencing and related methods and systems Jan. 14, 2025
-
Patent Title: Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization Oct. 01, 2024
-
Patent Title: Method for studying v(d)j combinatory diversity Oct. 03, 2023
-
Patent Title: Synthetic strands for nucleic acid sequencing and related methods and systems Jul. 25, 2023
-
Patent Title: Determining wt-1 specific t cells and wt-1 specific t cell receptors (tcrs) Jul. 19, 2022
-
Patent Title: Determining antigen-specific t-cells Mar. 01, 2022
-
Patent Title: Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements Feb. 22, 2022
-
Patent Title: Methods using randomer-containing synthetic molecules Feb. 15, 2022
-
Patent Title: Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization Nov. 23, 2021
-
Patent Title: Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing Jul. 20, 2021
-
Patent Title: Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing Jun. 29, 2021
-
Patent Title: Method of identifying human compatible t cell receptors specific for an antigenic target Jun. 22, 2021
-
Patent Title: Monitoring health and disease status using clonotype profiles Jun. 01, 2021
-
Patent Title: Methods of monitoring conditions by sequence analysis May. 11, 2021
-
Patent Title: Compositions and methods for measuring and calibrating amplification bias in multiplexed pcr reactions Jan. 19, 2021
-
Patent Title: Monitoring health and disease status using clonotype profiles Dec. 15, 2020
-
Patent Title: Monitoring health and disease status using clonotype profiles Sep. 01, 2020
-
Patent Title: Method for genotyping clonotype profiles using sequence tags Jan. 07, 2020
-
Patent Title: Monitoring health and disease status using clonotype profiles Dec. 31, 2019
-
Patent Title: Determining antigen-specific t-cells Oct. 08, 2019
-
Patent Title: Identification of antigen-specific b cell receptors Oct. 01, 2019
-
Patent Title: Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples Aug. 27, 2019
-
Patent Title: Random array sequencing of low-complexity libraries Aug. 20, 2019
-
Patent Title: Adaptive immunity profiling and methods for generation of monoclonal antibodies Jun. 18, 2019
-
Patent Title: Methods of monitoring conditions by sequence analysis Apr. 23, 2019
-
Patent Title: Methods of monitoring conditions by sequence analysis Apr. 02, 2019
-
Patent Title: Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture Apr. 02, 2019
-
Patent Title: Diagnosis of lymphoid malignancies and minimal residual disease detection Nov. 21, 2017
-
Patent Title: Method for generating clonotype profiles using sequence tags Jul. 18, 2017
-
Patent Title: Rare clonotypes and uses thereof Dec. 27, 2016
-
Patent Title: Sequence analysis of complex amplicons Dec. 20, 2016
-
Patent Title: Monitoring health and disease status using clonotype profiles Dec. 06, 2016
-
Patent Title: Method of sequence determination using sequence tags Nov. 29, 2016
-
Patent Title: Detection and measurement of tissue-infiltrating lymphocytes Nov. 22, 2016
-
Patent Title: Monitoring health and disease status using clonotype profiles Aug. 16, 2016
-
Patent Title: Detection and quantification of sample contamination in immune repertoire analysis Jul. 19, 2016
-
Patent Title: Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions Jun. 21, 2016
-
Patent Title: Monitoring immunoglobulin heavy chain evolution in b-cell acute lymphoblastic leukemia Jun. 14, 2016
-
Patent Title: Single cell analysis by polymerase cycling assembly May. 24, 2016
-
Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Mar. 08, 2016
-
Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Nov. 10, 2015
-
Patent Title: Quantification of adaptive immune cell genomes in a complex mixture of cells Nov. 10, 2015
-
Patent Title: Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions Oct. 06, 2015
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded to ADPT from public contracts
ADPT News
Recent insights relating to ADPT
CNBC Recommendations
Recent picks made for ADPT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ADPT
ADPT Analyst Ratings
ADPT Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
ADPT Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $ADPT stock a Buy, Sell, or Hold?
- What is the price target for $ADPT stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
ADPT Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $ADPT stock?
- Who owns the most shares of $ADPT stock?
- What funds own $ADPT stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
ADPT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ADPT Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
About ADPT
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
- Address Seattle, WA
- Market Cap 4.7 billion
- Employees 624
- Industrial Classification Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corporation Common Stock (ADPT) Historical Stock Prices
Adaptive Biotechnologies Corporation Common Stock (ADPT) closed at $29.57 on September 24, 2026. Over the past year its adjusted close ranged from $12.41 to $29.57. Daily prices go back to June 25, 2014, 2,531 trading days in all.
- 1 month+12.65%
- 3 months+46.02%
- Year to date+82.08%
- 1 year+130.66%
- 3 years+482.09%
- 5 years-18.96%
- Max+14.83%
See every congressional and insider trade on the ADPT price chart
Quiver Premium charts ADPT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | 28.00 | 29.58 | 27.50 | 29.57 | 29.57 | 3,610,497 |
| Sep 23, 2026 | 27.74 | 28.35 | 27.60 | 27.89 | 27.89 | 1,079,717 |
| Sep 22, 2026 | 27.30 | 28.36 | 26.73 | 28.06 | 28.06 | 4,000,158 |
| Sep 21, 2026 | 28.69 | 28.78 | 27.70 | 27.86 | 27.86 | 1,458,727 |
| Sep 18, 2026 | 28.55 | 28.68 | 27.91 | 28.61 | 28.61 | 2,985,539 |
| Sep 17, 2026 | 28.23 | 28.72 | 27.77 | 28.55 | 28.55 | 3,279,757 |
| Sep 16, 2026 | 27.09 | 28.72 | 27.03 | 27.67 | 27.67 | 5,026,486 |
| Sep 15, 2026 | 24.80 | 27.34 | 24.71 | 26.68 | 26.68 | 4,124,280 |
| Sep 14, 2026 | 24.26 | 24.88 | 23.96 | 24.78 | 24.78 | 1,730,383 |
| Sep 11, 2026 | 24.23 | 24.79 | 23.93 | 24.20 | 24.20 | 1,238,268 |
| Sep 10, 2026 | 23.81 | 24.65 | 23.53 | 24.23 | 24.23 | 1,071,432 |
| Sep 9, 2026 | 24.05 | 24.68 | 23.89 | 24.42 | 24.42 | 1,106,844 |
| Sep 8, 2026 | 23.98 | 24.60 | 23.62 | 24.34 | 24.34 | 1,358,580 |
| Sep 4, 2026 | 24.06 | 24.40 | 23.94 | 24.28 | 24.28 | 1,404,316 |
| Sep 3, 2026 | 25.18 | 25.36 | 23.84 | 24.57 | 24.57 | 2,161,036 |
| Sep 2, 2026 | 24.40 | 25.23 | 24.18 | 24.66 | 24.66 | 1,623,149 |
| Sep 1, 2026 | 24.91 | 25.11 | 24.20 | 24.34 | 24.34 | 1,621,010 |
| Aug 31, 2026 | 24.61 | 25.02 | 23.86 | 24.92 | 24.92 | 2,237,634 |
| Aug 28, 2026 | 26.54 | 26.58 | 25.13 | 25.19 | 25.19 | 1,509,096 |
| Aug 27, 2026 | 26.23 | 26.87 | 26.11 | 26.44 | 26.44 | 1,944,721 |
| Aug 26, 2026 | 26.00 | 26.51 | 25.82 | 26.16 | 26.16 | 1,387,277 |
| Aug 25, 2026 | 25.80 | 26.49 | 25.23 | 26.25 | 26.25 | 1,221,787 |
| Aug 24, 2026 | 25.80 | 25.99 | 25.09 | 25.55 | 25.55 | 1,694,427 |
| Aug 21, 2026 | 25.37 | 26.03 | 24.93 | 25.99 | 25.99 | 1,816,948 |
| Aug 20, 2026 | 24.78 | 26.09 | 24.78 | 25.44 | 25.44 | 1,966,210 |
| Aug 19, 2026 | 25.38 | 26.16 | 25.16 | 25.49 | 25.49 | 2,145,837 |
| Aug 18, 2026 | 24.24 | 25.15 | 23.92 | 24.56 | 24.56 | 1,878,377 |
| Aug 17, 2026 | 24.45 | 25.64 | 24.45 | 24.77 | 24.77 | 2,668,386 |
| Aug 14, 2026 | 24.27 | 24.95 | 24.00 | 24.74 | 24.74 | 1,743,593 |
| Aug 13, 2026 | 25.54 | 25.54 | 24.41 | 24.46 | 24.46 | 1,537,646 |
| Aug 12, 2026 | 25.34 | 25.54 | 24.86 | 25.25 | 25.25 | 1,706,891 |
| Aug 11, 2026 | 25.38 | 26.09 | 25.01 | 25.39 | 25.39 | 2,956,649 |
| Aug 10, 2026 | 24.90 | 26.16 | 24.65 | 25.45 | 25.45 | 2,366,094 |
| Aug 7, 2026 | 24.69 | 24.95 | 24.28 | 24.93 | 24.93 | 2,495,201 |
| Aug 6, 2026 | 24.58 | 24.58 | 23.41 | 23.60 | 23.60 | 2,466,112 |
| Aug 5, 2026 | 24.54 | 24.96 | 24.22 | 24.60 | 24.60 | 2,415,866 |
| Aug 4, 2026 | 23.60 | 24.62 | 23.03 | 24.55 | 24.55 | 3,291,487 |
| Aug 3, 2026 | 22.91 | 23.56 | 21.83 | 23.11 | 23.11 | 2,591,235 |
| Jul 31, 2026 | 24.57 | 24.57 | 22.41 | 22.57 | 22.57 | 2,993,184 |
| Jul 30, 2026 | 22.20 | 24.34 | 22.07 | 24.18 | 24.18 | 5,284,113 |
| Jul 29, 2026 | 22.48 | 23.08 | 21.74 | 22.56 | 22.56 | 3,147,510 |
| Jul 28, 2026 | 22.72 | 22.99 | 21.93 | 22.52 | 22.52 | 1,678,937 |
| Jul 27, 2026 | 22.70 | 23.00 | 21.78 | 22.54 | 22.54 | 2,437,487 |
| Jul 24, 2026 | 22.56 | 22.77 | 21.83 | 22.27 | 22.27 | 2,819,965 |
| Jul 23, 2026 | 21.95 | 22.91 | 21.95 | 22.31 | 22.31 | 2,763,907 |
| Jul 22, 2026 | 22.25 | 22.65 | 21.54 | 21.95 | 21.95 | 2,355,574 |
| Jul 21, 2026 | 21.63 | 22.60 | 20.90 | 22.58 | 22.58 | 3,505,218 |
| Jul 20, 2026 | 22.54 | 22.90 | 21.63 | 21.86 | 21.86 | 2,140,016 |
| Jul 17, 2026 | 21.43 | 23.02 | 21.36 | 22.92 | 22.92 | 3,233,067 |
| Jul 16, 2026 | 22.88 | 23.15 | 21.46 | 22.10 | 22.10 | 2,447,739 |
| Jul 15, 2026 | 21.77 | 22.99 | 21.69 | 22.90 | 22.90 | 3,986,034 |
| Jul 14, 2026 | 21.16 | 21.54 | 20.84 | 21.43 | 21.43 | 1,889,331 |
| Jul 13, 2026 | 20.76 | 21.55 | 20.46 | 21.02 | 21.02 | 1,844,673 |
| Jul 10, 2026 | 21.92 | 22.13 | 20.72 | 21.06 | 21.06 | 1,907,792 |
| Jul 9, 2026 | 20.39 | 21.94 | 20.25 | 21.80 | 21.80 | 3,005,961 |
| Jul 8, 2026 | 20.11 | 20.57 | 19.77 | 20.16 | 20.16 | 2,513,999 |
| Jul 7, 2026 | 21.37 | 21.63 | 20.45 | 20.82 | 20.82 | 2,440,474 |
| Jul 6, 2026 | 21.11 | 21.90 | 21.00 | 21.50 | 21.50 | 2,525,680 |
| Jul 2, 2026 | 22.50 | 22.80 | 21.09 | 21.19 | 21.19 | 3,393,935 |
| Jul 1, 2026 | 21.46 | 22.54 | 21.40 | 22.37 | 22.37 | 3,284,993 |
| Jun 30, 2026 | 21.08 | 21.56 | 20.70 | 21.45 | 21.45 | 3,421,386 |
| Jun 29, 2026 | 21.20 | 21.64 | 20.73 | 21.40 | 21.40 | 3,524,441 |
| Jun 26, 2026 | 20.07 | 21.00 | 19.96 | 20.96 | 20.96 | 6,474,446 |
| Jun 25, 2026 | 19.61 | 20.64 | 19.53 | 20.25 | 20.25 | 3,961,781 |
| Jun 24, 2026 | 17.68 | 19.74 | 17.54 | 19.34 | 19.34 | 5,523,583 |
| Jun 23, 2026 | 17.14 | 17.89 | 17.13 | 17.23 | 17.23 | 2,272,806 |
| Jun 22, 2026 | 17.50 | 17.89 | 17.27 | 17.37 | 17.37 | 2,261,989 |
| Jun 18, 2026 | 17.11 | 17.57 | 17.00 | 17.53 | 17.53 | 3,883,147 |
| Jun 17, 2026 | 16.84 | 17.39 | 16.43 | 16.78 | 16.78 | 13,517,714 |
| Jun 16, 2026 | 16.16 | 18.06 | 15.90 | 17.22 | 17.22 | 6,864,844 |
| Jun 15, 2026 | 18.38 | 18.38 | 17.13 | 17.46 | 17.46 | 2,852,780 |
| Jun 12, 2026 | 19.52 | 19.52 | 17.10 | 17.60 | 17.60 | 2,984,825 |
| Jun 11, 2026 | 17.72 | 19.31 | 16.80 | 18.73 | 18.73 | 5,433,572 |
| Jun 10, 2026 | 17.15 | 18.23 | 17.01 | 17.07 | 17.07 | 3,006,064 |
| Jun 9, 2026 | 16.93 | 17.53 | 16.54 | 17.36 | 17.36 | 2,216,600 |
| Jun 8, 2026 | 17.16 | 17.49 | 16.68 | 16.70 | 16.70 | 1,749,389 |
| Jun 5, 2026 | 17.90 | 18.29 | 16.68 | 16.90 | 16.90 | 2,164,035 |
| Jun 4, 2026 | 16.00 | 18.12 | 15.96 | 18.08 | 18.08 | 4,416,008 |
| Jun 3, 2026 | 15.05 | 16.00 | 14.76 | 15.99 | 15.99 | 2,236,706 |
| Jun 2, 2026 | 15.18 | 15.33 | 14.84 | 15.14 | 15.14 | 1,631,598 |
| Jun 1, 2026 | 14.99 | 15.47 | 14.74 | 15.23 | 15.23 | 1,571,654 |
| May 29, 2026 | 15.19 | 15.59 | 15.10 | 15.15 | 15.15 | 2,293,281 |
| May 28, 2026 | 13.87 | 15.22 | 13.81 | 15.19 | 15.19 | 1,579,192 |
| May 27, 2026 | 14.12 | 14.18 | 13.75 | 13.84 | 13.84 | 2,775,258 |
| May 26, 2026 | 14.00 | 14.19 | 13.66 | 14.13 | 14.13 | 904,542 |
| May 22, 2026 | 14.00 | 14.27 | 13.73 | 13.88 | 13.88 | 1,235,006 |
| May 21, 2026 | 13.74 | 13.92 | 13.39 | 13.87 | 13.87 | 1,075,842 |
| May 20, 2026 | 13.05 | 13.99 | 12.91 | 13.96 | 13.96 | 1,918,910 |
| May 19, 2026 | 12.71 | 13.02 | 12.53 | 12.96 | 12.96 | 1,247,172 |
| May 18, 2026 | 12.82 | 13.39 | 12.50 | 12.71 | 12.71 | 1,593,298 |
| May 15, 2026 | 12.93 | 13.15 | 12.81 | 12.83 | 12.83 | 1,563,597 |
| May 14, 2026 | 13.19 | 13.35 | 12.96 | 13.18 | 13.18 | 1,600,088 |
| May 13, 2026 | 13.54 | 13.57 | 12.95 | 13.13 | 13.13 | 1,285,899 |
| May 12, 2026 | 13.42 | 13.72 | 13.26 | 13.63 | 13.63 | 1,233,353 |
| May 11, 2026 | 13.91 | 14.10 | 13.43 | 13.54 | 13.54 | 1,505,374 |
| May 8, 2026 | 14.46 | 14.46 | 13.55 | 13.81 | 13.81 | 1,522,133 |
| May 7, 2026 | 14.58 | 15.06 | 14.22 | 14.69 | 14.69 | 1,950,183 |
| May 6, 2026 | 14.64 | 14.98 | 12.98 | 14.43 | 14.43 | 4,900,345 |
| May 5, 2026 | 14.74 | 14.83 | 13.64 | 13.78 | 13.78 | 3,187,717 |
| May 4, 2026 | 14.15 | 14.83 | 14.15 | 14.50 | 14.50 | 2,214,430 |
| May 1, 2026 | 14.20 | 14.40 | 14.03 | 14.27 | 14.27 | 983,568 |
| Apr 30, 2026 | 13.54 | 14.16 | 13.54 | 14.10 | 14.10 | 1,189,355 |
| Apr 29, 2026 | 13.89 | 14.06 | 13.22 | 13.53 | 13.53 | 1,274,599 |
| Apr 28, 2026 | 14.21 | 14.30 | 13.71 | 14.04 | 14.04 | 1,229,375 |
| Apr 27, 2026 | 14.03 | 14.36 | 14.03 | 14.21 | 14.21 | 1,063,436 |
| Apr 24, 2026 | 13.82 | 14.18 | 13.74 | 14.14 | 14.14 | 876,142 |
| Apr 23, 2026 | 14.18 | 14.45 | 13.50 | 13.82 | 13.82 | 1,006,072 |
| Apr 22, 2026 | 14.44 | 14.55 | 13.97 | 14.20 | 14.20 | 1,040,241 |
| Apr 21, 2026 | 14.59 | 15.15 | 14.16 | 14.21 | 14.21 | 1,531,228 |
| Apr 20, 2026 | 14.25 | 14.86 | 14.11 | 14.58 | 14.58 | 1,432,573 |
| Apr 17, 2026 | 14.55 | 14.91 | 14.38 | 14.47 | 14.47 | 1,592,873 |
| Apr 16, 2026 | 14.29 | 14.52 | 14.02 | 14.08 | 14.08 | 1,303,071 |
| Apr 15, 2026 | 14.53 | 14.86 | 14.44 | 14.53 | 14.53 | 949,024 |
| Apr 14, 2026 | 14.17 | 14.80 | 14.08 | 14.53 | 14.53 | 1,367,456 |
| Apr 13, 2026 | 12.83 | 14.27 | 12.82 | 14.13 | 14.13 | 3,126,170 |
| Apr 10, 2026 | 13.43 | 13.60 | 12.36 | 12.79 | 12.79 | 3,310,061 |
| Apr 9, 2026 | 14.70 | 14.73 | 13.37 | 13.40 | 13.40 | 1,740,008 |
| Apr 8, 2026 | 15.00 | 15.61 | 14.45 | 14.84 | 14.84 | 2,188,850 |
| Apr 7, 2026 | 13.95 | 14.06 | 13.39 | 13.71 | 13.71 | 1,405,532 |
| Apr 6, 2026 | 14.71 | 14.90 | 14.05 | 14.08 | 14.08 | 1,440,848 |
| Apr 2, 2026 | 13.81 | 14.89 | 13.81 | 14.81 | 14.81 | 1,565,438 |
| Apr 1, 2026 | 14.00 | 14.66 | 13.84 | 14.43 | 14.43 | 2,485,962 |
| Mar 31, 2026 | 13.14 | 13.90 | 13.09 | 13.88 | 13.88 | 2,401,889 |
| Mar 30, 2026 | 12.45 | 13.02 | 12.27 | 12.85 | 12.85 | 1,819,479 |
| Mar 27, 2026 | 13.84 | 13.86 | 12.02 | 12.41 | 12.41 | 4,948,162 |
| Mar 26, 2026 | 13.86 | 14.36 | 13.82 | 13.96 | 13.96 | 1,218,018 |
| Mar 25, 2026 | 14.23 | 14.51 | 13.94 | 14.15 | 14.15 | 2,165,486 |
| Mar 24, 2026 | 13.55 | 13.95 | 13.41 | 13.90 | 13.90 | 1,762,658 |
| Mar 23, 2026 | 14.00 | 14.12 | 13.57 | 13.66 | 13.66 | 1,274,969 |
| Mar 20, 2026 | 13.36 | 13.60 | 13.18 | 13.58 | 13.58 | 2,360,426 |
| Mar 19, 2026 | 13.10 | 13.60 | 12.97 | 13.50 | 13.50 | 1,336,947 |
| Mar 18, 2026 | 13.23 | 13.41 | 13.02 | 13.28 | 13.28 | 1,550,270 |
| Mar 17, 2026 | 13.35 | 13.67 | 13.13 | 13.39 | 13.39 | 1,735,605 |
| Mar 16, 2026 | 13.41 | 13.88 | 13.21 | 13.32 | 13.32 | 3,079,953 |
| Mar 13, 2026 | 13.05 | 13.28 | 12.69 | 13.17 | 13.17 | 3,902,533 |
| Mar 12, 2026 | 13.83 | 13.94 | 12.00 | 12.45 | 12.45 | 5,881,586 |
| Mar 11, 2026 | 14.38 | 14.39 | 13.81 | 14.22 | 14.22 | 2,109,877 |
| Mar 10, 2026 | 14.95 | 15.05 | 14.11 | 14.52 | 14.52 | 1,839,256 |
| Mar 9, 2026 | 14.50 | 15.16 | 14.21 | 14.95 | 14.95 | 3,493,672 |
| Mar 6, 2026 | 15.48 | 15.69 | 14.81 | 14.86 | 14.86 | 1,973,868 |
| Mar 5, 2026 | 16.20 | 16.35 | 15.74 | 15.93 | 15.93 | 1,850,893 |
| Mar 4, 2026 | 16.15 | 16.95 | 16.15 | 16.44 | 16.44 | 1,333,810 |
| Mar 3, 2026 | 15.54 | 16.56 | 15.11 | 16.08 | 16.08 | 1,777,426 |
| Mar 2, 2026 | 15.51 | 16.20 | 15.50 | 16.12 | 16.12 | 1,634,721 |
| Feb 27, 2026 | 16.23 | 16.23 | 15.80 | 16.02 | 16.02 | 2,050,105 |
| Feb 26, 2026 | 16.31 | 16.48 | 15.77 | 16.46 | 16.46 | 1,449,295 |
| Feb 25, 2026 | 16.18 | 16.50 | 15.85 | 16.21 | 16.21 | 1,078,182 |
| Feb 24, 2026 | 15.39 | 16.21 | 15.39 | 16.05 | 16.05 | 1,575,294 |
| Feb 23, 2026 | 14.82 | 15.48 | 14.75 | 15.39 | 15.39 | 1,843,757 |
| Feb 20, 2026 | 15.91 | 15.94 | 15.03 | 15.20 | 15.20 | 1,661,424 |
| Feb 19, 2026 | 15.74 | 16.18 | 15.57 | 16.05 | 16.05 | 1,056,400 |
| Feb 18, 2026 | 15.76 | 16.08 | 15.60 | 15.87 | 15.87 | 1,669,452 |
| Feb 17, 2026 | 15.98 | 16.35 | 15.71 | 15.79 | 15.79 | 1,022,077 |
| Feb 13, 2026 | 15.53 | 16.42 | 15.42 | 16.04 | 16.04 | 1,344,899 |
| Feb 12, 2026 | 15.66 | 15.81 | 15.07 | 15.54 | 15.54 | 1,632,464 |
| Feb 11, 2026 | 15.80 | 15.94 | 14.85 | 15.62 | 15.62 | 1,969,475 |
| Feb 10, 2026 | 15.84 | 16.08 | 15.48 | 15.64 | 15.64 | 1,334,563 |
| Feb 9, 2026 | 15.89 | 16.18 | 15.30 | 15.86 | 15.86 | 2,466,647 |
| Feb 6, 2026 | 17.82 | 17.98 | 15.06 | 15.77 | 15.77 | 4,140,316 |
| Feb 5, 2026 | 17.17 | 17.88 | 16.37 | 16.47 | 16.47 | 2,497,354 |
| Feb 4, 2026 | 18.46 | 18.50 | 16.87 | 17.30 | 17.30 | 2,166,897 |
| Feb 3, 2026 | 18.66 | 19.80 | 18.02 | 18.50 | 18.50 | 2,067,733 |
| Feb 2, 2026 | 18.29 | 18.88 | 18.13 | 18.39 | 18.39 | 2,249,189 |
| Jan 30, 2026 | 18.17 | 18.70 | 17.98 | 18.50 | 18.50 | 1,882,413 |
| Jan 29, 2026 | 18.41 | 18.48 | 17.65 | 18.37 | 18.37 | 1,547,577 |
| Jan 28, 2026 | 19.25 | 19.34 | 18.43 | 18.50 | 18.50 | 1,964,731 |
| Jan 27, 2026 | 19.20 | 19.42 | 18.75 | 19.23 | 19.23 | 1,377,574 |
| Jan 26, 2026 | 18.52 | 19.29 | 18.25 | 19.12 | 19.12 | 1,263,463 |
| Jan 23, 2026 | 19.05 | 19.10 | 18.24 | 18.55 | 18.55 | 1,342,836 |
| Jan 22, 2026 | 17.76 | 19.16 | 17.54 | 19.06 | 19.06 | 2,240,515 |
| Jan 21, 2026 | 17.79 | 17.99 | 17.32 | 17.57 | 17.57 | 1,668,114 |
| Jan 20, 2026 | 16.55 | 18.14 | 16.55 | 17.87 | 17.87 | 2,119,828 |
| Jan 16, 2026 | 17.79 | 17.89 | 17.40 | 17.52 | 17.52 | 1,042,637 |
| Jan 15, 2026 | 18.15 | 18.39 | 17.66 | 17.78 | 17.78 | 1,036,920 |
| Jan 14, 2026 | 17.98 | 18.18 | 17.56 | 18.04 | 18.04 | 1,866,379 |
| Jan 13, 2026 | 18.29 | 18.49 | 17.44 | 18.07 | 18.07 | 1,847,185 |
| Jan 12, 2026 | 17.51 | 18.50 | 17.32 | 18.26 | 18.26 | 3,587,884 |
| Jan 9, 2026 | 16.01 | 16.29 | 15.45 | 15.76 | 15.76 | 2,468,957 |
| Jan 8, 2026 | 16.52 | 16.81 | 15.53 | 15.96 | 15.96 | 2,074,384 |
| Jan 7, 2026 | 16.21 | 17.33 | 16.20 | 16.73 | 16.73 | 2,069,335 |
| Jan 6, 2026 | 16.17 | 16.82 | 15.78 | 16.11 | 16.11 | 3,352,311 |
| Jan 5, 2026 | 15.78 | 16.19 | 15.31 | 16.17 | 16.17 | 3,424,820 |
| Jan 2, 2026 | 16.27 | 16.47 | 15.74 | 15.91 | 15.91 | 1,060,412 |
| Dec 31, 2025 | 16.47 | 16.82 | 16.11 | 16.24 | 16.24 | 1,969,470 |
| Dec 30, 2025 | 16.54 | 16.62 | 16.05 | 16.42 | 16.42 | 1,529,659 |
| Dec 29, 2025 | 16.52 | 16.82 | 16.35 | 16.65 | 16.65 | 2,236,999 |
| Dec 26, 2025 | 16.64 | 17.04 | 16.48 | 16.70 | 16.70 | 909,652 |
| Dec 24, 2025 | 16.51 | 16.77 | 16.33 | 16.68 | 16.68 | 907,236 |
| Dec 23, 2025 | 17.21 | 17.42 | 16.66 | 16.75 | 16.75 | 2,271,564 |
| Dec 22, 2025 | 17.06 | 17.50 | 16.86 | 17.41 | 17.41 | 1,785,178 |
| Dec 19, 2025 | 16.51 | 17.17 | 16.34 | 17.00 | 17.00 | 2,852,081 |
| Dec 18, 2025 | 16.53 | 16.99 | 16.46 | 16.50 | 16.50 | 2,866,159 |
| Dec 17, 2025 | 15.81 | 16.48 | 15.60 | 16.12 | 16.12 | 2,430,932 |
| Dec 16, 2025 | 15.66 | 16.05 | 15.50 | 15.93 | 15.93 | 2,279,986 |
| Dec 15, 2025 | 16.03 | 16.08 | 15.35 | 15.69 | 15.69 | 3,004,642 |
| Dec 12, 2025 | 15.38 | 15.53 | 15.11 | 15.44 | 15.44 | 2,452,523 |
| Dec 11, 2025 | 15.74 | 16.07 | 14.94 | 15.42 | 15.42 | 2,298,439 |
| Dec 10, 2025 | 14.93 | 16.26 | 14.91 | 15.74 | 15.74 | 4,365,189 |
| Dec 9, 2025 | 14.74 | 15.62 | 14.69 | 14.86 | 14.86 | 3,453,268 |
| Dec 8, 2025 | 14.71 | 15.23 | 14.58 | 14.95 | 14.95 | 3,757,354 |
| Dec 5, 2025 | 16.24 | 16.25 | 14.65 | 14.75 | 14.75 | 7,131,157 |
| Dec 4, 2025 | 16.86 | 17.58 | 16.45 | 17.46 | 17.46 | 2,928,101 |
| Dec 3, 2025 | 18.87 | 18.87 | 16.50 | 17.13 | 17.13 | 4,712,963 |
| Dec 2, 2025 | 18.84 | 19.27 | 18.52 | 18.69 | 18.69 | 1,050,461 |
| Dec 1, 2025 | 19.26 | 19.31 | 18.59 | 18.84 | 18.84 | 1,944,007 |
| Nov 28, 2025 | 19.72 | 19.72 | 19.25 | 19.66 | 19.66 | 926,835 |
| Nov 26, 2025 | 20.23 | 20.34 | 19.40 | 19.72 | 19.72 | 1,880,510 |
| Nov 25, 2025 | 20.36 | 20.76 | 19.60 | 20.32 | 20.32 | 2,747,442 |
| Nov 24, 2025 | 18.95 | 20.65 | 18.40 | 20.46 | 20.46 | 4,345,909 |
| Nov 21, 2025 | 16.28 | 18.98 | 16.18 | 18.61 | 18.61 | 5,068,292 |
| Nov 20, 2025 | 15.57 | 16.97 | 15.57 | 16.32 | 16.32 | 3,968,168 |
| Nov 19, 2025 | 13.85 | 15.38 | 13.72 | 15.15 | 15.15 | 2,817,184 |
| Nov 18, 2025 | 13.53 | 13.95 | 13.28 | 13.75 | 13.75 | 1,992,804 |
| Nov 17, 2025 | 14.00 | 14.24 | 13.65 | 13.71 | 13.71 | 1,703,365 |
| Nov 14, 2025 | 13.71 | 14.21 | 13.45 | 14.10 | 14.10 | 1,627,684 |
| Nov 13, 2025 | 14.18 | 14.29 | 13.93 | 14.14 | 14.14 | 2,318,049 |
| Nov 12, 2025 | 14.64 | 15.05 | 14.36 | 14.50 | 14.50 | 1,731,962 |
| Nov 11, 2025 | 14.65 | 14.95 | 14.26 | 14.53 | 14.53 | 1,613,293 |
| Nov 10, 2025 | 14.88 | 15.19 | 14.35 | 14.71 | 14.71 | 2,748,024 |
| Nov 7, 2025 | 15.31 | 15.37 | 14.53 | 14.79 | 14.79 | 2,944,676 |
| Nov 6, 2025 | 16.95 | 17.38 | 15.38 | 15.56 | 15.56 | 3,634,017 |
| Nov 5, 2025 | 16.85 | 17.75 | 16.62 | 17.59 | 17.59 | 1,882,802 |
| Nov 4, 2025 | 16.77 | 17.51 | 16.51 | 16.92 | 16.92 | 1,347,783 |
| Nov 3, 2025 | 17.26 | 17.52 | 17.00 | 17.34 | 17.34 | 1,344,440 |
| Oct 31, 2025 | 16.90 | 17.76 | 16.81 | 17.36 | 17.36 | 1,910,994 |
| Oct 30, 2025 | 16.98 | 17.36 | 16.77 | 16.91 | 16.91 | 1,515,923 |
| Oct 29, 2025 | 16.91 | 17.40 | 16.59 | 16.80 | 16.80 | 1,039,255 |
| Oct 28, 2025 | 17.01 | 17.18 | 16.80 | 16.90 | 16.90 | 832,034 |
| Oct 27, 2025 | 17.26 | 17.48 | 16.97 | 17.12 | 17.12 | 820,181 |
| Oct 24, 2025 | 17.20 | 17.59 | 17.16 | 17.22 | 17.22 | 1,213,734 |
| Oct 23, 2025 | 16.44 | 17.38 | 16.39 | 17.16 | 17.16 | 1,637,277 |
| Oct 22, 2025 | 17.02 | 17.24 | 16.21 | 16.45 | 16.45 | 2,089,702 |
| Oct 21, 2025 | 17.79 | 17.89 | 17.08 | 17.35 | 17.35 | 2,025,014 |
| Oct 20, 2025 | 16.73 | 17.87 | 16.63 | 17.83 | 17.83 | 2,513,038 |
| Oct 17, 2025 | 17.00 | 17.20 | 16.28 | 16.30 | 16.30 | 1,575,388 |
| Oct 16, 2025 | 17.11 | 17.62 | 16.97 | 17.27 | 17.27 | 1,553,261 |
| Oct 15, 2025 | 16.00 | 17.14 | 15.91 | 17.11 | 17.11 | 2,047,116 |
| Oct 14, 2025 | 15.24 | 15.78 | 15.21 | 15.58 | 15.58 | 1,209,993 |
| Oct 13, 2025 | 15.50 | 15.94 | 15.21 | 15.50 | 15.50 | 1,486,463 |
| Oct 10, 2025 | 15.79 | 15.83 | 15.13 | 15.17 | 15.17 | 978,938 |
| Oct 9, 2025 | 15.57 | 15.68 | 15.17 | 15.65 | 15.65 | 1,494,777 |
| Oct 8, 2025 | 14.50 | 15.57 | 14.39 | 15.55 | 15.55 | 1,950,964 |
| Oct 7, 2025 | 14.47 | 14.56 | 14.11 | 14.35 | 14.35 | 1,780,197 |
| Oct 6, 2025 | 14.64 | 14.97 | 14.43 | 14.47 | 14.47 | 2,327,391 |
| Oct 3, 2025 | 14.38 | 14.89 | 14.16 | 14.38 | 14.38 | 2,128,948 |
| Oct 2, 2025 | 14.61 | 14.74 | 14.04 | 14.24 | 14.24 | 2,229,457 |
| Oct 1, 2025 | 14.93 | 15.26 | 14.52 | 14.56 | 14.56 | 2,679,819 |
| Sep 30, 2025 | 14.00 | 15.04 | 13.95 | 14.96 | 14.96 | 4,722,265 |
| Sep 29, 2025 | 13.38 | 13.65 | 13.07 | 13.46 | 13.46 | 1,716,618 |
| Sep 26, 2025 | 13.13 | 13.25 | 12.82 | 13.22 | 13.22 | 1,455,870 |
| Sep 25, 2025 | 12.62 | 13.33 | 12.51 | 13.13 | 13.13 | 1,668,303 |
| Sep 24, 2025 | 13.80 | 13.88 | 12.71 | 12.82 | 12.82 | 1,716,920 |
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
Need daily prices for every ticker, in code?
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver API
Adaptive Biotechnologies Corporation Common Stock Executive Compensation
We estimate that -- received a compensation of -- in --, making them the highest paid executive at ADPT, per a recent SEC DEF 14A filing. We estimate that the median employee at Adaptive Biotechnologies Corp is paid $170,306.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|